Purdue Settles OxyContin Patent Cases Against KV

Law360, New York (June 10, 2009, 12:00 AM EDT) -- Purdue Pharma LP has resolved patent infringement litigation against specialty pharmaceutical firm KV Pharmaceutical Co. and agreed to permit KV to launch generic versions of painkiller OxyContin for a limited time in the United States.

St. Louis-based KV said Wednesday the settlement brought an end to Purdue’s three lawsuits against it in the U.S. District Court for the Southern District of New York, according to a filing with the U.S. Securities and Exchange Commission.

Under the terms of the deal, KV agreed to acknowledge that Purdue’s...
To view the full article, register now.